» Articles » PMID: 19058925

The Association of Syringe Type and Syringe Cleaning with HCV Infection Among IDUs in Budapest, Hungary

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2008 Dec 9
PMID 19058925
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We assessed whether syringe type, syringe cleaning and distributive syringe sharing were associated with self-reported and laboratory-confirmed HCV infection among Hungarian IDUs. Injecting drug users (N=215) were recruited from non-treatment settings in Budapest, Hungary between October 2005 and December 2006. Multivariate logistic regression models identified correlates of self-report of being HCV infected and testing positive for HCV. While 37% tested positive for HCV, 14% of the total (39% of those who tested positive) self-reported being HCV infected. Using any two-piece syringes was significantly associated with self-reported HCV infection, while distributive syringe sharing was not associated with self-report of being HCV infected. Engaging in receptive sharing of only one-piece syringes but always cleaning before reuse was not associated with testing HCV positive, while any receptive sharing of only one-piece syringes and not always cleaning before reuse was significantly associated with testing HCV positive. Sharing cookers and squirting drugs from one syringe into another syringe were not associated with testing HCV positive. The high percent of those HCV infected who did not know they were infected highlights the need to provide better access to confidential testing and counseling services. Counseling should emphasize secondary prevention of HCV among HCV infected IDUs. Our findings also indicate that syringe type and syringe cleaning practices may play a role in HCV transmission. Ethnographic research should identify the reasons why IDUs may use two-piece syringes and suggest means to reduce their use. Thorough cleaning of one-piece syringes when sterile syringes are unavailable may be an efficient way to reduce the risk of HCV infection.

Citing Articles

Co-design of harm reduction materials for people who inject drugs to implement research findings.

Hussey D, Trinder-Widdess Z, Dee C, Bagnall D, Bojangles T, Kesten J Harm Reduct J. 2019; 16(1):36.

PMID: 31174536 PMC: 6555749. DOI: 10.1186/s12954-019-0300-z.


Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.

Trickey A, May M, Hope V, Ward Z, Desai M, Heinsbroek E Drug Alcohol Depend. 2018; 192:118-124.

PMID: 30245460 PMC: 6541923. DOI: 10.1016/j.drugalcdep.2018.07.041.


Prevalence of hepatitis C viral infection among injecting drug users in a Saudi Arabian hospital: A point cross sectional survey.

Alibrahim O, Misau Y, Mohammed A, Faruk M, Ss I J Public Health Afr. 2018; 9(1):726.

PMID: 30079162 PMC: 6057725. DOI: 10.4081/jphia.2018.726.


Options for reducing HIV transmission related to the dead space in needles and syringes.

Zule W, Pande P, Otiashvili D, Bobashev G, Friedman S, Gyarmathy V Harm Reduct J. 2018; 15(1):3.

PMID: 29334973 PMC: 5769352. DOI: 10.1186/s12954-017-0207-5.


Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England.

Kesten J, Ayres R, Neale J, Clark J, Vickerman P, Hickman M Int J Drug Policy. 2016; 39:99-108.

PMID: 27788406 PMC: 6688102. DOI: 10.1016/j.drugpo.2016.09.005.


References
1.
Racz J, Gyarmathy V, Neaigus A, Ujhelyi E . Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care. 2006; 19(1):59-66. PMC: 2597713. DOI: 10.1080/09540120600722742. View

2.
Purcell D, Mizuno Y, Metsch L, Garfein R, Tobin K, Knight K . Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J Urban Health. 2006; 83(4):656-68. PMC: 2430482. DOI: 10.1007/s11524-006-9066-1. View

3.
Koester S, Glanz J, Baron A . Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005; 9(1):27-39. DOI: 10.1007/s10461-005-1679-y. View

4.
Ompad D, Fuller C, Vlahov D, Thomas D, Strathdee S . Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis. 2002; 35(7):783-8. DOI: 10.1086/342063. View

5.
Abdala N, Gleghorn A, Carney J, Heimer R . Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. J Acquir Immune Defic Syndr. 2001; 28(5):487-94. DOI: 10.1097/00042560-200112150-00013. View